Inactive Instrument

Biofarm SA Stock Bucharest S.E.

Equities

Pharmaceuticals

End-of-day quote Bucharest S.E.
- RON - Intraday chart for Biofarm SA
Sales 2022 277M 59.99M Sales 2023 280M 60.71M Capitalization 812M 176M
Net income 2022 70M 15.16M Net income 2023 77M 16.68M EV / Sales 2022 1.89 x
Net cash position 2022 82.71M 17.91M Net cash position 2023 112M 24.18M EV / Sales 2023 2.5 x
P/E ratio 2022
9.31 x
P/E ratio 2023
11.6 x
Employees -
Yield 2022
4.87%
Yield 2023
3.76%
Free-Float 11.67%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 49 18-11-14
Director of Finance/CFO 44 21-01-17
Chief Administrative Officer 50 19-12-31
Members of the board TitleAgeSince
Chief Executive Officer 49 18-11-14
Director/Board Member 44 15-12-09
Director/Board Member 49 -
More insiders
Biofarm SA is a Romania-based company engaged in the pharmaceutical sector. The Company focuses on the production and marketing of pharmaceutical preparations. The Company is active in the manufacture and wholesale of over the counter drugs, prescription medications and dietary supplements. The Company’s product portfolio includes pharmaceutical preparations for digestive system, musculoskeletal system, immune stimulation, respiratory system, cold and flu symptoms and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants and cosmetics, among others. Additionally, the Company offers services, such as consultancy on Romanian pharmaceutical market, manufacturing of non-sterile products, the investment in research, promotion and packaging. The main shareholder of the Company is Societatea de Investitii Financiare Muntenia SA.
More about the company